Cansativa GmbH

Cansativa Group is a pharmaceutical company based in Moerfelden-Walldorf, Germany, with a mission to professionalize the medical cannabis market. Established in 2017, the company holds GMP and GDP certifications and is licensed for the manufacturing, import, and trade of pharmaceuticals and controlled substances. Cansativa aims to eliminate the stigma associated with medical cannabis and reduce prices for patients. As a pioneer in the industry, the company operates its own distribution and fulfillment center, making it one of the largest importers and distributors of medical cannabis in Germany. With a strong focus on supply security, Cansativa recently obtained manufacturing authorization for its facilities, further strengthening its position in the German market. The company's commitment to professionalizing the medical cannabis market, along with its strategic location in Germany, makes it an attractive prospect for potential investors seeking opportunities in the pharmaceutical and cannabis industries.